<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200211046464N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-05-04</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Effect of PRP in treatment of anosmia</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation the effectiveness of platelet-rich plasma in smell Improvement of Patients with nasal polyposis due to chronic sinusitis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2017-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>24</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/47132</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Block Random assignment, Blinding description: The patients are unaware of the type of intervention performed during general anesthesia and the technician who evaluates the outcome is not present during the surgical procedure. Surgeon in charge of injection.</study_design>
      <phase>3</phase>
      <hc_freetext>Condition 1: Nasal Polyp. Condition 2: Anosmia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Patients in both groups underwent sinus endoscopic surgery by only one specific ENT specialist. At this stage, in the intervention group, a platelet-rich plasma was injected into the patient's nose inside the operating room and during general anesthesia. To do this, platelet-rich plasma was injected with a 1 cc syringe in the olfactory area within 1 cm2 with the help of a nasal endoscope and by the same surgeon from specific ENT specialists. The whole process of preparing platelet-rich plasma was performed in the sports medicine group under the supervision of the sports medicine professor and using Arjangian platelet-rich plasma kits. The temperature during these steps to prevent plaque clots was 21-24. C. Intervention 2: Control group:After Functional endoscopic sinus surgery, in the control group, instead of platelet-rich plasma, normal saline serum was injected into the patient's olfactory area with the same amount and under the same conditions. The injector was also unaware of the group of patients and the injected substance.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Information about the main outcome after not identifying individuals

When:
6 months after printing the results

To whom:
Researchers working in academic and scientific institutions

Conditions:
Scientific research in academic institutions

Where to obtain:
Ali Goljanian Tabrizi; Ali.goljanian@gmail.com
Mahboobeh Asadi Amiri; Mahboobeh_farvardin@yahoo.com

How to obtain:
State the name, academic or professional rank, the applicant center and the reason for the application in your email. Files and documents will be sent about 1 month after the request is processed.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mehdi Mohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>floor 2., No. 11, Mohammadi Rd., East Kourosh St., North Janat Abad Blvd</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1477835814</zip>
        <telephone>+98 21 4483 3279</telephone>
        <email>Dr.md.mohammadi@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ali Goljanian Tabrizi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>ENT Department., Taleghani Hospital., Next to Shahid Beheshti University of Medical Sciences., Shahid Arabi St., Yemen St., Shahid Chamran Highway</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985711151</zip>
        <telephone>+98 21 2303 1111</telephone>
        <email>ali.goljanian@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 15 and 50 years
Having chronic sinusitis with polyps
Anosmia lasts less than 2 years
Existence of anosmia confirmed by olfactory diagnosis test</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Suffering from systemic diseases such as diabetes mellitus, Parkinson's and Alzheimer's
smoking
Head injury history
Previous surgical history of paranasal sinuses
Congenital anosmia</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>J33</hc_code>
      <hc_code>R43.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Nasal polyp</hc_keyword>
      <hc_keyword>Anosmia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Patients in both groups underwent sinus endoscopic surgery by only one specific ENT specialist. At this stage, in the intervention group, a platelet-rich plasma was injected into the patient's nose inside the operating room and during general anesthesia. To do this, platelet-rich plasma was injected with a 1 cc syringe in the olfactory area within 1 cm2 with the help of a nasal endoscope and by the same surgeon from specific ENT specialists. The whole process of preparing platelet-rich plasma was performed in the sports medicine group under the supervision of the sports medicine professor and using Arjangian platelet-rich plasma kits. The temperature during these steps to prevent plaque clots was 21-24. C.</i_keyword>
      <i_keyword>Control group:After Functional endoscopic sinus surgery, in the control group, instead of platelet-rich plasma, normal saline serum was injected into the patient's olfactory area with the same amount and under the same conditions. The injector was also unaware of the group of patients and the injected substance.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Olfactory score less than 6 in the Iranian Smell Identification Test. Timepoint: Measurement of olfactory score at the beginning of the study (before the intervention), After receiving oral treatment and 3 months after surgery and injection of platelet-rich plasma. Method of measurement: Iranian Smell Identification Test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-04-23</approval_date>
        <contact_name>Iran National committee for Ethics in Biomedical Research</contact_name>
        <contact_address>floor 2., No. 11, Mohammadi Rd., East Kourosh St., North Janat Abad Blvd Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
